Compounds > leflunomide

leflunomide and foscarnet

leflunomide has been researched along with foscarnet in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's1 (8.33)29.6817
2010's9 (75.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Waldman, WJ; Williams, JW1
Avery, RK; Bolwell, BJ; Curtis, J; Kalaycio, M; Kohn, D; Long, JR; Longworth, DL; Lurain, N; Mossad, SB; Pohlman, B; Taege, AJ; Waldman, WJ; Williams, JW; Yen-Lieberman, B1
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H1
Beersma, MF; Boucher, CA; Falkenburg, F; Hoek, RA; Hoogsteden, HC; Jedema, I; Murk, JL; Pas, SD; Schipper, ME; van Bergeijk, H; van den Blink, B; van Hal, PT; Verkaik, NJ1
Behr, J; Giessen, C; Jäger, G; Kneidinger, N; Milger, K; Neurohr, C; Nitschko, H; Schramm, R; Striebinger, H; von Wulffen, W1
Ambrose, T; Butler, A; Carmichael, A; Duncan, S; English, S; Gkrania-Klotsas, E; Louis-Auguste, J; Massey, D; Middleton, S; Russell, N; Rutter, CS; Sharkey, LM; Woodward, JM1
Ariza-Heredia, E; Chemaly, RF; Doan, V; El Chaer, F; Jan, A; Mori, N; Oliver, N; Shah, D; Tayar, J; Tverdek, F; Wang, E1
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L1
Al-Aloul, M; Fu, L; Jones, NP; Santhanakrishnan, K; Steeples, LR1

Reviews

3 review(s) available for leflunomide and foscarnet

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:6

    Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Isoxazoles; Leflunomide; Lung Transplantation; Middle Aged; Viral Load

2013
Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
    Ocular immunology and inflammation, 2020, Oct-02, Volume: 28, Issue:7

    Topics: Antiviral Agents; Cytomegalovirus Retinitis; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leflunomide; Lung Transplantation; Male; Middle Aged; Transplant Recipients

2020

Other Studies

9 other study(ies) available for leflunomide and foscarnet

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
    Transplantation, 1999, Sep-27, Volume: 68, Issue:6

    Topics: Antiviral Agents; Blotting, Northern; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Endothelium, Vascular; Fibroblasts; Foscarnet; Gene Expression; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Time Factors; Transcription, Genetic; Umbilical Veins; Viral Proteins; Virus Replication

1999
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
    Bone marrow transplantation, 2004, Volume: 34, Issue:12

    Topics: Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure; Middle Aged; Salvage Therapy; Transplantation, Homologous; Viral Load

2004
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
    Transplantation, 2012, Apr-15, Volume: 93, Issue:7

    Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome

2012
Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 28

    Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Leflunomide; Lung Transplantation; Monitoring, Immunologic; Transplant Recipients

2014
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
    Transplantation proceedings, 2016, Volume: 48, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intestines; Isoxazoles; Leflunomide; Male; Middle Aged; Retrospective Studies; Viremia

2016
Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
    Antiviral research, 2016, Volume: 135

    Topics: Aged; Antiviral Agents; Chemotherapy, Adjuvant; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Salvage Therapy; Transplant Recipients; Virus Activation

2016
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplantation proceedings, 2017, Volume: 49, Issue:7

    Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors

2017